Market Place
Sourcing Support
Merck to Cut 8% of Workforce, Laying Off 6,000
31 Jul 2025 //
FIERCE PHARMA
Merck Axes Main Asset from $1.9 B Pandion Buyout
30 Jul 2025 //
FIERCE BIOTECH
Merck Cuts $3 B to Support Aggressive Launch Schedule
30 Jul 2025 //
BIOSPACE
Merck & Co Announces Q2 2025 Financial Results
29 Jul 2025 //
BUSINESSWIRE
Merck`s Biologics Keytruda Receives Suppl Approval in US
24 Jul 2025 //
FDA
Merck Announces Fourth-Quarter 2025 Dividend
22 Jul 2025 //
BUSINESSWIRE
Merck Adopts Veeva Vault CRM
21 Jul 2025 //
CONTRACTPHARMA
EU Grants Conditional Approval of Ezmekly for Patient with NF1-PN
18 Jul 2025 //
GLOBENEWSWIRE
Merck Introduces AAW Workstation for Lab Automation Advancement
15 Jul 2025 //
INDPHARMAPOST
Merck to Start Phase 3 Trials for Monthly HIV Prevention Pill
14 Jul 2025 //
BUSINESSWIRE
FDA Gives Nod to Merck`s Bravecto Quantum
11 Jul 2025 //
INDPHARMAPOST
Merck`s Doravirine/Islatravir NDA Accepted by FDA
10 Jul 2025 //
BUSINESSWIRE
Merck Animal Health`s Bravecto® Quantum Gets FDA Approval
10 Jul 2025 //
BUSINESSWIRE
China`s 9-valent HPV vaccine priced at 60% discount to Merck jab
10 Jul 2025 //
FIERCE PHARMA
Merck Nears $10 Billion Deal for Respiratory Drugmaker Verona
10 Jul 2025 //
PRESS RELEASE
Merck to Unveil Hiv Prevention, Treatment Data at IAS 2025
09 Jul 2025 //
INDPHARMAPOST
Certara Expands Clinical Tech Collaboration with Merck
08 Jul 2025 //
GLOBENEWSWIRE
FDA Grants Priority Review for Winrevair Label Update
02 Jul 2025 //
BUSINESSWIRE
Merck`s Q2 2025 Sales and Earnings Call Set for July 29
01 Jul 2025 //
BUSINESSWIRE
ACIP Backs Merck’s ENFLONSIA for RSV in Infants
26 Jun 2025 //
BUSINESSWIRE
US CDC vaccine panel postpones vote on RSV therapies
25 Jun 2025 //
REUTERS
Merck Investor Event: Advancing HIV Treatment Research
24 Jun 2025 //
BUSINESSWIRE
Merck`s WINREVAIR™ Met Primary Endpoint in PAH Study
23 Jun 2025 //
BUSINESSWIRE
IDeate-Prostate01 Phase 3 Trial of Ifinatamab Deruxtecan Begins
18 Jun 2025 //
BUSINESSWIRE
Keytruda Nod Highlights CEL-SCI Opportunity in PD-L1– Cancers
18 Jun 2025 //
BUSINESSWIRE
Keytruda`s Novel Head and Neck Cancer Nod Comes with A Limit
14 Jun 2025 //
BUSINESSWIRE
FDA Approves Keytruda for Local Advanced Head & Neck Cancer
13 Jun 2025 //
BUSINESSWIRE
Merck Initiates Phase 3 Study Evaluating Dengue Vaccine Candidate
13 Jun 2025 //
BUSINESSWIRE
Merck Animal Health gets EU CVMP nod for Numelvi
12 Jun 2025 //
BUSINESSWIRE
FDA limits Merck`s Keytruda, BMS` Opdivo in Stomach Cancer
10 Jun 2025 //
FIERCE PHARMA
US FDA Approves Merck`s RSV Antibody for Infants
10 Jun 2025 //
REUTERS
Merck`s Cholesterol Drug Meets Main Goal in Two Studies
09 Jun 2025 //
REUTERS
Merck to Join 46th Annual Goldman Sachs Healthcare Conference
04 Jun 2025 //
BUSINESSWIRE
Merck made $3B offer for MoonLake & could revive interest
04 Jun 2025 //
FINANCIALTIMES
Arcus Kidney Cancer Drug Casdatifan Advances to Challenge Welireg
03 Jun 2025 //
BIOSPACE
Merck`s MK-1084 Shows Antitumor Activity in Phase 1 Trial
30 May 2025 //
BUSINESSWIRE
Merck takes middle dose of ROR ADC forward into phase 3
30 May 2025 //
BUSINESSWIRE
Patritumab Deruxtecan BLA Withdrawn for EGFR-Mutated Lung Cancer
29 May 2025 //
BUSINESSWIRE
Pimicotinib shows high efficacy in tenosynovial Giant Cell Tumor
29 May 2025 //
INDPHARMAPOST
Daiichi, Merck pull HER3-DXd filing at FDA
29 May 2025 //
REUTERS
Merck Announces Third-Quarter 2025 Dividend
27 May 2025 //
BUSINESSWIRE
Merck’s Ph2 Data For Enpatoran Shows SLE Rash Improvement
22 May 2025 //
INDPHARMAPOST
AZ, Merck Duke It out To Lead Oncologists’ Pharma Perceptions
22 May 2025 //
FIERCE PHARMA
Merck`s Biologics Keytruda Receives Suppl Approval in US
22 May 2025 //
FDA
Merck to Join Bernstein 41st Annual Strategic Decisions Conf.
22 May 2025 //
BUSINESSWIRE
Merck Showcases Innovation in Advanced Cancers and Rare Tumors
22 May 2025 //
BUSINESSWIRE
Antengene & MSD Enter into a Global Clinical Collaboration
21 May 2025 //
PR NEWSWIRE
Orion’s collaborator MSD expands Opevesostat for Women`s Cancers
21 May 2025 //
PRESS RELEASE
IDeate-Esophageal01 Phase 3 Trial of Ifinatamab Deruxtecan Begins
19 May 2025 //
BUSINESSWIRE
Merck to Share PAH Research at ATS 2025 Conference
16 May 2025 //
BUSINESSWIRE
Merck`s Phase 3 KEYNOTE-B96 Trial Meets Primary Endpoint
15 May 2025 //
BUSINESSWIRE
FDA expands use of Merck`s cancer drug for adrenal gland tumors
15 May 2025 //
REUTERS
FDA Approves Merck’s Welireg for Rare PPGL Tumor Treatment
14 May 2025 //
BUSINESSWIRE
Merck to Present Oncology Advances at ASCO 2025
13 May 2025 //
BUSINESSWIRE
Merck Animal Health, Kansas to Invest $895M in De Soto Facilities
08 May 2025 //
BUSINESSWIRE
Merck to Join Bank of America 2025 Healthcare Conference
07 May 2025 //
BUSINESSWIRE
Dawn Health, Merck Launch Digital Ecosystem for Growth Disorders
07 May 2025 //
PR NEWSWIRE
AmacaThera, Merck Animal Health Collaborate in Animal Health
01 May 2025 //
PR NEWSWIRE
Merck starts $1 billion Biologics Center in Delaware, US
30 Apr 2025 //
PRESS RELEASE
Keytruda improves survival in head and neck Cancer
27 Apr 2025 //
BUSINESSWIRE
